Research Associate I, Clinical Biomarker Development

Revolution Medicines•Redwood City, CA

2d•Hybrid

About The Position

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. We are seeking a Research Associate I to join our Clinical Biomarker Development team. The selected candidate will play a vital role in supporting clinical biomarker leads in implementing biomarker strategies for RAS(ON) inhibitor clinical trials. This role offers the chance to work in a collaborative and innovative environment while contributing to ongoing clinical studies.

Requirements

Masters in cancer biology, cell or molecular biology, or a related field with 0-1 years of relevant experience.
Excellent organizational skills, strong attention to detail, and effective time management with the ability to adapt to shifting priorities.
Strong written and verbal communication skills.
Proficiency in quality control of scientific data.
Ability to thrive in detail-oriented work within fast-paced, team-based environments.

Nice To Haves

Hands on experience with data science languages such as R, Python, and SQL.
Understanding of oncology drug development, clinical trial design, and biomarker integration.
Familiarity with clinically relevant biomarker platforms, including NGS and qPCR/ddPCR.

Responsibilities

Collaborate with Clinical Biomarker Leads, Biomarker Scientists and other Translational Medicine team members in Clinical Biomarker Operations and Clinical Bioinformatics to support the execution of biomarker strategies.
Perform quality control (QC) on study-related biomarker data and figures that lead to scientific presentations.
Conduct detailed review of clinically relevant documents for RAS(ON) inhibitor clinical trials to ensure data accuracy, integrity, and compliance with study protocols.
Work with Clinical Biomarker Operations to facilitate biomarker sample testing and maintain inventories of biomarker samples to support study planning and biomarker data delivery.
Perform routine analysis of biomarker data under close supervision.